植物起源的神经药理干预对帕金森病:全面评估
Umar Muzaffer1, Bisma Gull2, Zabeer Ahmed3
1Department of Medicine, Govt, Medical College and Associated SMHS Hospital Srinagar, J&K-190001, India.
Current neuropharmacology
|May 30, 2025
概括
本综述探讨了传统草药和计算方法如何为帕金森病 (PD) 提供新的治疗策略. 将古代智慧与现代科学相结合,为管理这种神经退行性疾病提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 帕金森病 (PD) 是一种复杂的神经退行性疾病,治疗选择有限.
- 创新方法对于有效的PD管理至关重要.
研究的目的:
- 审查PD传统草药配方的治疗潜力.
- 在PD研究中探索计算方法的应用.
- 突出结合草药和PD干预的计算技术.
主要方法:
- 对PD中传统草药配方的综合文献综述.
- 计算技术的检查:分子对接,分子动力学模拟,药模拟和网络药理学.
- 对协同效应和作用机制的分析.
主要成果:
- 传统的草药配方在PD治疗中表现有前途.
- 计算方法为药物发现和了解疾病机制提供了强大的工具.
- 两种方法的整合可以产生协同作用的治疗效果.
结论:
- 将传统的草药知识与计算方法相结合,为开发新的帕金森病疗法提供了有希望的途径.
- 这种综合策略有助于更深入地了解PD的发病和治疗.
- 未来的研究应该专注于验证这些综合方法的临床应用.
相关概念视频
01:24Parkinson's Disease: Treatment
995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
01:28Drug Therapy
246
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
246
01:22Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:37Neural Regulation
43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K